CRYSTAL LAKE, Ill., Oct 23 — AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma, effective January 1, 2027.
Maes joins Aptar from Amcor, where she currently leads its global Flexibles Pharma and Medical packaging business, spanning North America, Latin America, EMEA and Asia. During her career at Amcor, she has held senior leadership roles across pharma, medical, strategy and business development. She brings extensive experience in global customer relationships, growth and transformation, operational performance and building highly engaged teams. Earlier in her career, Maes worked at McKinsey & Company, Terra Firma Capital Partners and Morgan Stanley. She holds an MBA from Harvard Business School, a Master’s in Financial Management from Vlerick Business School and a Master’s in Applied Economics from Ghent University.
“Virginie brings significant global experience, a strong customer focus and a proven ability to lead and grow complex businesses. I am confident she is the right leader to take our Pharma business forward,” said Gael Touya, President and Chief Executive Officer of Aptar. “She will lead a business with strong market positions, deep scientific and technical expertise and significant bench strength. Our focus is on continuing to become the partner of choice for our customers, solving their most complex challenges and creating value beyond the product.”
“I am excited to join Aptar and a Pharma business with strong leadership positions, deep expertise and a clear commitment to its customers,” said Virginie Maes. “The opportunity to work alongside our teams and customers to help them succeed, bringing together our technologies, services and expertise across the value chain from formulation through commercialization is what I’m most enthusiastic about. Ultimately, everything we do should be focused on helping our customers deliver solutions that support patients and improve their lives.”